| What it does | AI-powered trading platform for backtesting, paper trading and live algo trading on US stocks and ETFs
| Stock ratings for US stocks based on published research signals
|
|---|
| Stage | Not given
| Startup
|
|---|
| Founded | Not given
| 2025
|
|---|
| Based in | Not given
| PL
|
|---|
| Pricing model | Freemium
| Freemium
|
|---|
| Pricing | Free plan (no time limit, no card required): replay, trading journal, backtests and paper trading. Trader: $29/month or $290/year includes Spyglass AI (up to 30 messages/day), unlimited replays, overfitting checks. Quant: $79/month or $790/year adds live trading, 75 Spyglass messages/day, unlimited
| Free plan with limited access to 200 largest stocks. Paid Tessera plan: $2 for first month, then $29/month, billed monthly. Cancel anytime. 30-day money-back guarantee.
|
|---|
| Key features | - Spyglass AI: describe any setup or indicator and it builds and tests the strategy
- Market replay to practice trading past market days without risking money
- Trading journal to import, replay and analyze your trades
- Backtesting with overfitting checks to validate strategies on historical data
- Paper trading to deploy strategies risk-free against live market data
- Live trading with broker connection and risk controls
- Dead Man's Switch to close positions if browser stops responding
- No coding required; builds strategies from natural language descriptions
- Access to 11,511 US stocks and ETFs
- Portfolio analytics including expectancy, MAE, MFE and performance attribution
| - Six published research signals averaged into stock ratings
- Free access to ratings on the 200 largest US stocks
- Company financial analysis and sector comparisons
- Stock screening on valuation, profitability, growth and momentum
- Rules-based paper portfolio tracking with simulated trading
- Custom paper portfolios with historical backtesting
- Analyst estimates and DCF valuation tools
- CSV export for custom analysis
- Rating changes tracked weekly by signal
|
|---|
| What makes it different | - AI builds strategies from plain language without any coding needed
- Complete workflow from practice to live trading in one platform
- Overfitting checks built in to every strategy test
- Replay any past trade on the chart to learn from it
- Free plan with no time limit and no card required
| - Connects stock screening with company research and paper portfolio tracking in one workspace
- Ratings based on six published academic research signals, not proprietary black boxes
- Free access to research on largest 200 stocks, no credit card required
- Educational research and ranking signals, explicitly not investment advice
- Affordable paid plan at $2 first month then $29/month with backtesting and full universe access
|
| Community votes | 0 | 0 |
| DR (Domain Rating by Ahrefs) | 1 ● no change since last check | 4 ● no change since last check |
| Trust Flow (Majestic) | 2 | 3 |
| Citation Flow (Majestic) | 12 | 19 |
| Referring domains (Majestic) | 8 | 9 |